Cadila Healthcare has informed that the company has enclosed a copy of press release dated February 3, 2020 titled ‘Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes.’ The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.